| __timestamp | Regeneron Pharmaceuticals, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 504755000 | 10811000 |
| Thursday, January 1, 2015 | 838526000 | 33001000 |
| Friday, January 1, 2016 | 1177697000 | 64936000 |
| Sunday, January 1, 2017 | 1320433000 | 99909000 |
| Monday, January 1, 2018 | 1556200000 | 127724000 |
| Tuesday, January 1, 2019 | 1834800000 | 161524000 |
| Wednesday, January 1, 2020 | 1346000000 | 182933000 |
| Friday, January 1, 2021 | 1824900000 | 219982000 |
| Saturday, January 1, 2022 | 2115900000 | 278139000 |
| Sunday, January 1, 2023 | 2631300000 | 309799000 |
| Monday, January 1, 2024 | 2954400000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Regeneron Pharmaceuticals, Inc. and Ultragenyx Pharmaceutical Inc. have taken different paths in optimizing these costs. From 2014 to 2023, Regeneron saw a steady increase in SG&A expenses, peaking at approximately $2.63 billion in 2023, reflecting a 420% rise from 2014. In contrast, Ultragenyx's SG&A expenses grew from $10.8 million in 2014 to $310 million in 2023, marking a staggering 2,770% increase. This stark difference highlights Regeneron's more stable growth strategy compared to Ultragenyx's rapid expansion. As the pharmaceutical landscape evolves, these companies' approaches to cost management will be pivotal in determining their future market positions.
SG&A Efficiency Analysis: Comparing Novartis AG and Regeneron Pharmaceuticals, Inc.
Pfizer Inc. or Regeneron Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Regeneron Pharmaceuticals, Inc. or Viatris Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and Exelixis, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Apellis Pharmaceuticals, Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs MorphoSys AG Trends and Insights
Regeneron Pharmaceuticals, Inc. or Ligand Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Regeneron Pharmaceuticals, Inc. and Galapagos NV: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Novavax, Inc.
Lantheus Holdings, Inc. or Ultragenyx Pharmaceutical Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Alpine Immune Sciences, Inc. and Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?